Today's Top Alzheimer's News
Lilly plans a new solanezumab late-stage trial, research linking Alzheimer's and cancer could put us closer to finding a treatment, and an innovative caregiving model developed in the Netherlands (read more).
- A July 12, 2013 Reuters article reported that "Eli Lilly plans this year to begin a new late-stage trial of solanezumab, its experimental treatment for Alzheimer's disease that failed in earlier testing to significantly slow progression of the memory-robbing disease, the U.S. drugmaker said on Friday."
- A July 11, 2013 CBS News article reported that recent research finding cancer may protect against Alzheimer's could lead to new treatments. According to study author Dr. Massimo Musicco, an Alzheimer's expert at the National Research Council of Italy in Milan, "Since the number of cases of both Alzheimer's disease and cancer increase exponentially as people age, understanding the mechanisms behind this relationship may help us better develop new treatments for both diseases."
- A July 11, 2013 USA Today article reported that "The first glimpse of an upcoming Glen Campbell documentary will be unveiled July 25 in New York at Music Cures, a fundraiser staged by The Kaneff Foundation for the Alzheimer's Drug Discovery Foundation." Glen Campbell was diagnosed with Alzheimer's in 2011.
- A July 11, 2013 CNN article reported on the efforts of a care home in the Netherlands to develop a new dementia care model. According to the article, "'Dementia Village' - as it has become known -- is a place where residents can live a seemingly normal life, but in reality are being watched all the time. Caretakers staff the restaurant, grocery store, hair salon and theater -- although the residents don't always realize they are carers -- and are also watching in the residents' living quarters."
- A July 12, 2013 Alzheimer's Association press release announced that "The Alzheimer's Association and the Brin Wojcicki Foundation announced today that massive amounts of new data have been generated by the first "Big Data" project for Alzheimer's disease."